California Pacific Medical Center Now a Heart Hope Center.SAN FRANCISCO -- Heart Hope Offers Destination Therapy, an Implanted Mechanical Circulatory Heart Assist Device, to Persons with Heart Failure Who Do Not Quality for a Heart Transplant California Pacific Medical Center California Pacific Medical Center (CPMC) is one of the largest private, not-for-profit, academic medical centers in Northern California. The Medical Center is a combination of three of San Francisco's oldest medical institutions: Pacific Presbyterian Hospital, Children's Hospital is pleased to announce that it is now a Heart Hope Center. As a Heart Hope Center, (www.hearthope.com) California Pacific offers the latest technology for treating heart failure, including Thoratec's HeartMate(R) LVAD LVAD left ventricular assist device; see ventricular assist device, under device. -- an implanted mechanical circulatory heart assist device -- to persons with heart failure who do not qualify for a heart transplant (so-called "Destination Therapy"). The HeartMate(R) allows such patients to return to near-normal heart function. HeartMate(R) is an implantable long-term LVAD designed to take over the pumping function of the heart. The fist-sized device uses titanium parts that do not destroy blood cells blood cells, n.pl the formed elements of the blood, including red cells (erythrocytes), white cells (leukocytes), and platelets (thrombocytes). blood cells See erythrocyte and leukocyte. Platelets are classed separately. and the inner surface become lined with the patient's own endothelial cells Endothelial cells The cells lining the inner walls of the blood vessels. Mentioned in: Von Willebrand Disease as blood flows through it, diminishing rejection and allowing for long-term usage. Destination Therapy can offer advanced heart failure patients an opportunity to restore functional status to a near normal state. Heart failure occurs when heart muscle doesn't pump as much blood as the body needs. Failure doesn't mean the heart has stopped pumping -- rather, it simply means it's not pumping as effectively as it should. Nearly 5 million Americans are currently living with heart failure, with 550,000 new cases diagnosed each year. The Heart Hope initiative is a collaboration between Thoratec Corporation (www.thoratec.com) headquartered in Pleasanton, California and leading heart centers committed to advancing clinical outcomes associated with mechanical circulatory assist devices and other advanced therapies in the treatment of heart failure. California Pacific has already been using Thoratec's HeartMate(R) LVAD as a "bridge-to-transplant" therapy for patients waiting a donor organ. This left ventricular assist device left ventricular assist device Cardiology A mechanical device to ↑ force and volume of blood flowing through the heart. Cf CABG, Jarvik-7. (LVAD) is now the only LVAD with Destination Therapy FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval (November 2002) for end-stage heart failure End-stage heart failure Severe heart disease that does not respond adequately to medical or surgical treatment. Mentioned in: Heart Transplantation patients who are not eligible for heart transplant. California Pacific Medical Center is one of only eighteen Heart Hope Centers nationwide and the only Heart Hope Center in Northern California. Each Heart Hope Center must meet strict criteria for Medicare and Medicaid Medicare and Medicaid U.S. government programs in effect since 1966. Medicare covers most people 65 or older and those with long-term disabilities. Part A, a hospital insurance plan, also pays for home health visits and hospice care. coverage for Destination Therapy and participate in a national registry to benchmark clinical outcomes. About California Pacific Medical Center California Pacific Medical Center, a Sutter Health affiliate, is one of the largest private, not-for-profit teaching medical centers in Northern California. We are a tertiary referral center providing access to leading-edge medicine while delivering the best possible personalized care. CPMC CPMC California Pacific Medical Center (San Francisco) CPMC Columbia-Presbyterian Medical Center CPMC Colorado Plains Medical Center CPMC Centre Pierre et Marie Curie (French) provides a wide variety of services, including, acute, post-acute and outpatient hospital care; home care and hospice services; preventive and complementary care; and health education. Through our Medical Education Program and our Research Institute, physicians at California Pacific Medical Center are able to bring health care innovation to the bedside. About Dr. Soon J. Park Soon John Park, M.D., M.S., is the Chair of the Department of Cardiovascular and Thoracic Surgery and Surgical Director of Cardiac Transplantation at California Pacific Medical Center. He is also the Director of Cardiovascular Surgery at Marin General Hospital and serves as consultant to the cardiac program at St. Luke's Hospital in San Francisco. Dr. Park is a widely respected cardiovascular and thoracic surgeon and researcher. He is known for his pioneering work in the fields of circulatory support and thoracic transplantation. Prior to joining our collaborative program, Dr. Park was professor of Surgery and practiced at the University of Minnesota Medical School The University of Minnesota Medical School is the medical school of the University of Minnesota. It is a combination of two campuses situated in Minneapolis and Duluth, Minnesota. where he was the Director of the Circulatory Assist Program, Director of the HeartMate-VE Training, and Surgical Director of Thoracic Transplantation Program (Heart, Lung and Heart-lung). Additionally, he was the first recipient of the St. Jude Medical St. Jude Medical, Inc. NYSE: STJ is a $2.9 billion global cardiovascular device company, with headquarters in St. Paul, Minnesota, United States. The company sells products in more than 100 countries and has over 20 operations and manufacturing facilities worldwide. Chair in Biomedical Engineering at the University of Minnesota (body, education) University of Minnesota - The home of Gopher. http://umn.edu/. Address: Minneapolis, Minnesota, USA. . About Dr. Ernest Haeusslein Ernest Haeusslein, M.D., is Medical Director of the Heart Failure, Artificial Heart & Transplant Program and has been a member of the California Pacific transplant team since 1989. Dr. Haeusslein is responsible for the medical management and care of all patients throughout the transplant process, from evaluation to post-transplant follow up. His special interests include end-stage heart disease management and pharmaceutical investigation. He manages a special clinical program for heart failure patients in conjunction with his heart transplant clinic. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion